EXPONENT INC (EXPO)
Industrials · Technical and Engineering Consulting · NASDAQ
Exponent is a premier scientific and engineering consulting firm that helps clients navigate complex product failures, safety concerns, and regulatory challenges.
What EXPONENT INC does
Exponent is a multi-disciplinary engineering and scientific consulting firm that provides solutions for complex technical, regulatory, and business problems. The company serves clients by investigating failures, assessing risks, and providing research and development support across diverse industries. Its professional staff comprises hundreds of scientists and engineers with expertise in various technical disciplines.
Themes: litigation support, product safety and reliability, industrial engineering consulting, environmental and regulatory compliance
Fundamentals
- Price$69.81 as of 2026-10-09 close
- Market cap$3.3B as of 2026-07-31 (share count; price 2026-10-09)
- 1-year return+6.9% 2025-10-09 close $65.28 → 2026-10-09 close $69.81
- P/E32.58 as of 2026-10-09
- Net margin+18.2% FY2026, SEC XBRL
- ROE+27.2% FY2026, SEC XBRL
- Debt / equity0.00 as of 2026-09-03
- Revenue growth (YoY)+7.8% as of 2026-09-03
- Revenue CAGR (3y)+3.2% SEC XBRL
- Beta0.54 as of 2026-09-03
- Last reported earnings2026-07-30 SEC EDGAR Form 8-K (Item 2.02)
Dividend: yield +1.8%; at least 2 years of non-decreasing per-share dividends (SEC XBRL) — we do not hold the year before it, so the real streak may be longer.
How EXPO compares in its sector
- price-to-earnings ratiomiddle range 349 covered Industrials peers, as of 2026-10-09
- net profit margintop 10% 417 covered Industrials peers, as of 2026-09-03
- operating margintop 10% 392 covered Industrials peers, as of 2026-09-03
- return on equitytop 25% 432 covered Industrials peers, as of 2026-09-03
- 3-year revenue CAGRmiddle range 428 covered Industrials peers
- indicated dividend yieldmiddle range 271 covered Industrials peers, as of 2026-09-03
- free cash flow (absolute dollars, latest fiscal year)middle range 417 covered Industrials peers, as of FY2026
Position among covered Industrials companies that report each metric (minimum 5 peers). A relative position within our covered catalog — not a valuation, quality, or investment judgment. A higher percentile is simply a higher value (for P/E, more expensive on earnings — never "better"). Informational only.
Top 10 scores & list membership
EXPO is not currently in any published Top 10 list. Its scores are below.
Top 10 score
57.1 #354 of 1,383 scored · #45 of 238 in Industrials
Financial health 86th (debt to equity 0, free cash flow margin 21%) and profitability 80th (return on equity 27.2%, operating margin 20.6%); weakest is valuation (25th, price to book 11.5, price to earnings 32.6).
Scores as of 9 Oct 2026. Each bar is a percentile: how this company ranked against every company the score ranked, 0–100. A list is a published formula and its output, not a recommendation. Method version 4.
Dividend coverage (FY2026)
Covered by reported results. In FY2026, EXPO's dividend was covered by reported results (earnings payout 58%, free-cash-flow payout 50%). This describes past coverage, not a forecast.
- Earnings payout58% dividends / net income
- Free-cash-flow payout50% dividends / (operating cash flow − capex)
Coverage derived from reported SEC EDGAR XBRL figures for FY2026 (dividends paid vs. net income and free cash flow, same fiscal year). This describes PAST coverage for one fiscal year — it does not predict whether a dividend will be maintained, raised, or cut, and a one-year payout ratio can be distorted by non-recurring items. Informational only — not financial advice.
How EXPONENT INC looks technically
EXPONENT INC (EXPO) is trading 4.8% above its 200-day average, the long-term trend line — a longer-term uptrend. Its 50-day average crossed above its 200-day average about 13 trading days ago — a "golden cross", a bullish long-term signal. There is no clear trend right now — the price is choppy (ADX, a 0–100 trend-strength gauge, is 18, below the 25 that marks a real trend). Momentum is neutral — its 14-day RSI (a 0–100 momentum gauge) is 59, neither overbought (above 70) nor oversold (below 30). MACD, a trend-momentum gauge, turned bullish about 6 trading days ago (its momentum flipped positive). It made a new 20-day low about 11 trading days ago.
Trend
8
| Distance from the 200-day | it is trading 4.8% above its 200-day average, the long-term trend line — a longer-term uptrend | +4.8% |
|---|---|---|
| 50-day moving average | its average price over the last 50 trading days — a short-term trend line — is $68.10 | $68.10 |
| 200-day moving average | its average price over the last 200 trading days — the long-term trend line — is $66.64 | $66.64 |
| Swing structure | its recent peaks and dips disagree — one of them is rising while the other is not, so there is no clean up or down pattern in the swings | mixed — one of the two is not confirming |
| Last swing turn | its last significant turn was a swing high 7 calendar days ago — the swings before that are what the structure reading is measured on | 7 sessions |
| Since the 50/200 cross | its 50-day average crossed above its 200-day average about 13 trading days ago — a "golden cross", a bullish long-term signal | 13 sessions |
| Above the 200-day after a dip | it recently dipped to its 200-day average (the long-term trend line) and has since climbed back above it — now about 4.8% above | +4.8% |
| Trend strength (14-day ADX) | there is no clear trend right now — the price is choppy (ADX, a 0–100 trend-strength gauge, is 18, below the 25 that marks a real trend) | 17.6 |
Momentum
3
| 14-day RSI | momentum is neutral — its 14-day RSI (a 0–100 momentum gauge) is 59, neither overbought (above 70) nor oversold (below 30) | 58.7 |
|---|---|---|
| Position in its 14-day range | it is trading near the top of its 14-day range ($62.55 to $70.67) — its "stochastic" reading is 89 out of 100, where 0 would mean closing exactly at the 14-session low and 100 exactly at the high. This measures WHERE the price sits inside its recent range, which is a different question from the RSI beside it: RSI is a momentum gauge, measuring how FAST the price has been moving, so a stock can drift quietly to the bottom of its range with an ordinary RSI, or fall sharply and still sit in the middle. It has been climbing within that range over the last few sessions. | 89.4 |
| Since the MACD crossed zero | MACD, a trend-momentum gauge, turned bullish about 6 trading days ago (its momentum flipped positive) | 6 sessions |
Range
12
| 52-week high | its highest closing price over the past year (about 252 trading days) was $81.92 | $81.92 |
|---|---|---|
| From the 52-week high | it is 14.8% below its 52-week high (its highest price of the past year) | -14.8% |
| Above the 52-week low | it is 34.5% above its 52-week low (its lowest price of the past year) | +34.5% |
| Below the 52-week high | it is 14.8% below its highest point of the past year | 14.8% |
| Since a 20-day breakout | it made a new 20-day low about 11 trading days ago | 11 sessions |
| Since a 55-day breakout | it made a new 55-day high about 30 trading days ago | 30 sessions |
| All-time high | its highest closing price on record is $127.61 (set on 2021-11-22) | $127.61 |
| Given back of the 52-week move | over the past year its closes ranged ($53.67 to $79.79), and it has recovered a bit over half of its fall from last year’s high — 62% of it. Chart-watchers call 61.8%-65% given back the "golden pocket" — for this company that is $69.81 to $70.65. It is watched widely enough that orders cluster there, which is the honest reason it matters; it is not a forecast. | 61.8% |
| From the all-time high | it is 45.3% below its all-time high | -45.3% |
| Nearest price level | it is trading 0.8% below a resistance level at $70.41 — a price it turned at four times since 2025-10-22, most recently on 2026-10-02. Since 2024-10-09 it has 4 such levels below the current price and 9 above. Levels like these describe where the price has reversed or paused before; they are not a forecast of where it will go. | +0.8% |
| All-time low | its lowest closing price on record is $3.31 (set on 2005-08-12) | $3.31 |
| Above the all-time low | it is 2007.5% above its all-time low | +2,007% |
Volatility
5
| Band width vs its own 6 months | day-to-day price swings are about average versus its own recent 6-month history | 63rd percentile |
|---|---|---|
| Typical daily range | in a typical session it travels about $1.92 between its high and its low — about 2.8% of its price. That is its "average true range" over the last 14 sessions, which also counts the distance from the previous close, so a day that opens well away from yesterday counts as the large move it was | $1.92 |
| Bollinger bands (20-day, ±2σ) | most of its recent trading has stayed between about $63.42 and $71.22 — the "Bollinger bands", a range drawn two standard deviations either side of its 20-day average price, which widens when the stock gets more volatile and narrows when it settles | $63.42 – $67.32 – $71.22 |
| Typical daily range (% of price) | its price moves about 2.8% in a typical session — calmer than most companies we cover. This is the average gap between a session's high and low over the last 14 sessions, counting overnight moves, expressed against the current price so it can be compared with companies trading at any price | 2.8% |
| Stretch from the 200-day average | it is trading 1.7 daily ranges above its 200-day average price (4.8% above it in plain percentage terms) — a way of asking how far it has stretched from its own average in units of how far it normally moves in a day, so a calm company and a jumpy one can be compared on the same scale | 1.7 daily ranges above its 200-day average |
Volume
1
| Volume vs its 30-day average | trading volume is about normal versus its 30-day average | 0.57× |
|---|
Analyst
2
| Change in the average price target | analysts' average price target is unchanged from the prior reading | 0.0% |
|---|---|---|
| Change in the consensus rating | the analyst consensus rating is unchanged since the prior reading | unchanged |
Candlestick patterns
1
| Since a doji | 2 sessions ago it opened and closed at almost the same price after trading through a wider range — a "doji", the classic picture of buyers and sellers finishing the session level | 2 sessions ago |
|---|
Price gaps
2
| Gap at the open | it opened on 2026-10-09 0.3% above the previous session's close — an overnight gap, the part of the move that happened while the market was shut, and traded back through that level before the close | +0.3% |
|---|---|---|
| Gap filled | a 2.5% gap down opened on 2026-09-01 has been "filled" 27 sessions ago — price traded back through the level the gap left behind, and it closed again during the very session that opened it | 27 sessions ago |
Price streaks
1
| Closing streak | it has closed higher 2 sessions in a row, a +1.25% move over the run — an unbroken run of up days, which describes what has already happened and says nothing about the next session | 2 sessions up |
|---|
Relative strength
4
| vs market, 1 month | over the past 1 month this stock beat the market by 1.3 percentage points (the stock gained 3.5% while the market gained 2.1%) | +1.4% |
|---|---|---|
| vs market, 3 months | over the past 3 months this stock beat the market by 8.7 percentage points (the stock gained 12.3% while the market gained 3.6%) | +8.7% |
| vs market, 6 months | over the past 6 months this stock lagged the market by 9.8 percentage points (the stock gained 4.7% while the market gained 14.5%) | -9.8% |
| vs market, 12 months | over the past 12 months this stock lagged the market by 9.1 percentage points (the stock gained 6.9% while the market gained 16.0%) | -9.1% |
Signal agreement
2
| Bullish technical signals | 4 of the 9 technical signals we can compute for it are currently in a bullish state: a "golden cross" — its 50-day average is above its 200-day, trading above its 200-day average, MACD momentum is positive, trading above the Ichimoku cloud — these describe past price behaviour, not a forecast | 4 of 9 |
|---|---|---|
| Bearish technical signals | 2 of the 9 technical signals we can compute for it are currently in a bearish state: lagging the market over 6 months, near the top of its 14-day range (overbought) — these describe past price behaviour, not a forecast | 2 of 9 |
Trend (Ichimoku cloud)
1
| Vs the Ichimoku cloud | trading 1.4% above the Ichimoku cloud — a band drawn from where its own highs and lows sat up to 2026-09-02 and projected forward over today's price, the side traders read as an established uptrend, with the band below acting as the level that would have to give way. The band itself is thick, spanning 8.4% of the share price, which is taken to mean a barrier that has held for a while and takes effort to cross. | +1.4% |
|---|
Volume-weighted price
2
| Vs this year’s average price paid | the price is 6% above the average price paid so far this year, so the typical buyer over that stretch is showing a gain. That average is $65.74 — a volume-weighted average of daily closes over 191 sessions, not a true tick-by-tick VWAP. | +6.2% |
|---|---|---|
| Vs the average paid since it last reported | the price is 3% above the average price paid since it last reported on 2026-07-30 (its 8-K), so the typical buyer over that stretch is showing a gain. That average is $67.82 — a volume-weighted average of daily closes over 51 sessions, not a true tick-by-tick VWAP. | +2.9% |
Double top, bearish — forming · entry $64.18 · 29 sessions in
Price levels it has turned at before
EXPO last closed at $69.81 on 2026-10-09. Since 2024-10-09 it has turned at 4 prices below its last close and 9 above; the 3 nearest below and the 3 nearest above are listed, nearest first.
| Level | Side | Distance | Evidence |
|---|---|---|---|
| $70.41 | Resistance | 0.8% above the last close | turned there four times · 2025-10-22 to 2026-10-02 |
| $68.87 | Support | 1.3% below the last close | turned there 9 times · 2025-08-18 to 2026-08-03 |
| $72.67 | Resistance | 4.1% above the last close | turned there 8 times · 2025-05-02 to 2026-08-28 |
| $65.23 | Support | 6.6% below the last close | turned there four times · 2025-10-30 to 2026-07-17 |
| $74.62 | Resistance | 6.9% above the last close | turned there five times · 2025-04-07 to 2026-03-04 |
| $63.73 | Support | 8.7% below the last close | turned there six times · 2025-08-01 to 2026-09-28 |
A level is a price this company reversed or paused at more than once — they describe past behaviour, not a forecast of where the price will go.
Wave structure
No Elliott-wave labelling currently fits its swings: the recent highs and lows do not satisfy the three rules a five-wave count has to obey, so there is no count to show rather than a count we are unsure about.
Read from daily closes as of 2026-10-09.
An Elliott-wave count describes the swings already printed and the level that would disprove it. It is not a forecast, a target, or advice.
Screens: Trading above the 200-day moving average · Recent golden cross (50-day crossed above 200-day) · Tested and reclaimed 200-day support · trendless / choppy (low ADX) · lagging the market · At the top of its 14-day range (stochastic above 80) | Learn: moving average · golden cross · adx · rsi · macd · breakout
Based on daily closing prices as of 2026-10-09. Describes past price behavior only — informational, not financial advice.
Analyst consensus
- Consensus ratingBuy (1.75 mean, 1=Strong Buy…5=Strong Sell) — 3 analysts
- Mean price target$84.00 range $72.00 – $90.00; median $90.00
Analyst estimates, as of 2026-10-08. These are third-party analyst opinions and price targets, aggregated — not a recommendation, prediction, or advice from stocks-llm. Informational only.
Analyst EPS estimate for EXPO
- Consensus EPS estimate$0.6208 next reporting period, as of 2026-10-08
- Estimate change, 30 days-$0.025 (-3.9%) from $0.6458, on 2026-09-03, 35-day window
- Readings revised upward11% of 9 comparable readings
The consensus estimate for the next reporting period, and how it has moved between readings of that SAME period. A change is measured only between readings estimating one period — when a company reports, the consensus moves to the next quarter and the two numbers are not comparable. Informational only, not a forecast and not advice.
Key risks (from latest filing)
["Dependence on highly skilled professional staff to maintain technical expertise and reputation.","Exposure to potential professional liability claims and litigation arising from consulting services.","Fluctuations in project demand based on client industries and regulatory environments."]
What changed in the latest 10-Q
AI-assisted comparison of EXPO's 10-Q filed 2026-08-07 against the prior one filed 2026-05-08.
Management's Discussion & Analysis (MD&A)
- Added:
- Newer filing (2026-08-07) states critical accounting estimates disclosure covers the six months ended July 3, 2026.
- Newer filing (2026-08-07) includes an Executive Summary with Q2 2026 revenues of $171,612,000, a 21% increase compared to $141,962,000 in the prior-year period.
- Newer filing (2026-08-07) includes Q2 2026 revenues before reimbursements of $148,860,000, a 12% increase compared to $132,868,000.
- Newer filing (2026-08-07) states Q2 2026 net income increased 11% to $29,395,000 compared to $26,553,000.
- Newer filing (2026-08-07) states Q2 2026 diluted EPS increased to $0.60 per share compared to $0.52.
- Newer filing (2026-08-07) states billable hours increased 9% to 390,000 in Q2 2026 from 359,000 in the prior-year quarter.
- Newer filing (2026-08-07) states utilization increased to 74% in Q2 2026 from 72%.
- Newer filing (2026-08-07) states average technical full-time equivalent employees increased 6% to 1,012 in Q2 2026 from 958.
- Newer filing (2026-08-07) provides a revenue table for Q2 2026 vs Q2 2025 showing Engineering and Other Scientific at $148,829,000 vs $120,980,000 (23.0% change) and Environmental and Health at $22,783,000 vs $20,982,000 (8.6% change).
- Newer filing (2026-08-07) states Engineering and Other Scientific segment growth was driven by user research studies in consumer electronics and risk management in the utilities industry, along with reactive engagements across consumer products, chemicals, and transportation industries.
- Newer filing (2026-08-07) states Engineering and Other Scientific segment Q2 2026 billable hours increased 10% to 320,000 from 291,000.
- Newer filing (2026-08-07) states Engineering and Other Scientific segment utilization increased to 76% in Q2 2026 from 74%.
- Newer filing (2026-08-07) states Engineering and Other Scientific segment average technical full-time equivalent employees increased 7% to 810 in Q2 2026 from 756.
- Newer filing (2026-08-07) states Environmental and Health segment growth was driven by engagements evaluating the impacts of chemicals on human health and the environment.
- Newer filing (2026-08-07) states Environmental and Health segment Q2 2026 billable hours increased 3% to 70,000 from 68,000.
- Newer filing (2026-08-07) states Environmental and Health segment utilization increased to 66% in Q2 2026 from 65%.
- Newer filing (2026-08-07) includes a description of proactive work including a large user research study representing approximately 4% of net revenues during the quarter.
- Newer filing (2026-08-07) states proactive activity was also supported by increased risk management and infrastructure-related engagements in the utility sector.
- Newer filing (2026-08-07) states the revenue increase for Engineering and Other Scientific was due to an increase in billable hours, increase in billing rates and an increase in revenues from reimbursements associated with user research projects.
- Removed:
- Older filing (2026-05-08) states critical accounting estimates disclosure covers the three months ended April 3, 2026.
- Older filing (2026-05-08) includes an Executive Summary with Q1 2026 revenues of $166,303,000, a 14% increase compared to $145,507,000.
- Older filing (2026-05-08) includes Q1 2026 revenues before reimbursements of $151,817,000, a 10% increase compared to $137,437,000.
- Older filing (2026-05-08) states Q1 2026 net income increased 11% to $29,569,000 compared to $26,650,000.
- Older filing (2026-05-08) states Q1 2026 diluted EPS increased to $0.59 per share compared to $0.52.
- Older filing (2026-05-08) discusses a negative tax impact associated with stock-based awards of $896,000 in Q1 2026 compared to $469,000 in the prior-year quarter.
- Older filing (2026-05-08) states billable hours increased 6% to 399,000 in Q1 2026 from 376,000.
- Older filing (2026-05-08) states utilization increased 1% to 76% in Q1 2026 from 75%.
- Older filing (2026-05-08) states technical full-time equivalent employees increased 5% to 1,013 in Q1 2026 from 966.
- Older filing (2026-05-08) provides a revenue table for Q1 2026 vs Q1 2025 showing Engineering and Other Scientific at $141,412,000 vs $122,135,000 (15.8% change) and Environmental and Health at $24,891,000 vs $23,372,000 (6.5% change).
- Older filing (2026-05-08) states Engineering and Other Scientific segment growth was primarily driven by user research studies in consumer electronics and risk management in the utilities sector, along with reactive engagements in the energy and life sciences sectors.
- Older filing (2026-05-08) states Engineering and Other Scientific segment Q1 2026 billable hours increased 9% to 327,000 from 300,000.
- Older filing (2026-05-08) states Engineering and Other Scientific segment utilization increased to 77% in Q1 2026 from 76%.
- Older filing (2026-05-08) states Engineering and Other Scientific segment technical full-time equivalent employees increased 7% to 814 in Q1 2026 from 762.
- Older filing (2026-05-08) states Environmental and Health segment growth was primarily driven by regulatory consulting in the chemical industry.
- Older filing (2026-05-08) states Environmental and Health segment Q1 2026 billable hours decreased 5% to 72,000 from 76,000.
- Older filing (2026-05-08) states Environmental and Health segment utilization decreased to 69% in Q1 2026.
- Older filing (2026-05-08) states revenue growth was driven by proactive engagements including user research studies for consumer electronics clients integrating artificial intelligence into their devices, and risk management work for utility clients evaluating asset performance under extreme weather conditions.
- Older filing (2026-05-08) states reactive engagements contributed to growth with increased dispute-related and failure analysis demand across construction projects, energy facilities, and medical devices.
- Reworded:
- The critical accounting estimates disclosure updated from 'three months ended April 3, 2026' (older) to 'six months ended July 3, 2026' (newer).
- The Executive Summary quarter changed from Q1 2026 (older) to Q2 2026 (newer).
- The revenue discussion segment drivers changed from 'user research studies in consumer electronics and risk management in the utilities sector, along with reactive engagements in the energy and life sciences sectors' (older) to 'user research studies in consumer electronics and risk management in the utilities industry, along with reactive engagements across the consumer products, chemicals, and transportation industries' (newer).
- Environmental and Health segment growth driver changed from 'regulatory consulting in the chemical industry' (older) to 'engagements evaluating the impacts of chemicals on human health and the environment' (newer).
- Proactive work description changed from 'user research studies for consumer electronics clients integrating artificial intelligence into their devices' (older) to 'user research studies as clients accelerate the development of AI-enabled products across an increasingly diverse range of hardware form factors and applications' (newer).
- Notes:
- The newer filing text is truncated mid-sentence in the Environmental and Health segment discussion; the full newer text may contain additional changes not captured.
- The older filing text is also truncated mid-sentence in the Environmental and Health segment discussion.
- Only the portion of MD&A provided was compared; other parts of the MD&A section may contain changes not reflected here.
AI-assisted comparison of two SEC filing sections. It describes wording and theme changes only, makes no materiality, legal, or investment judgement, and is not financial advice. Informational only — not financial advice.
Insider activity (SEC Form 4)
1 open-market purchase and 2 open-market sales by insiders in the last 90 days, of which we have read Form 4 filings through 2026-10-05. The 5 days since 2026-10-05 have not been checked yet.
- Last 30 days · read to 2026-10-051 buy ($12594) · 0 sells — 1 buying insider
- Last 90 days · read to 2026-10-051 buy ($12594) · 2 sells ($222181) — 1 buying, 1 selling insiders
- Last 180 days · read to 2026-10-051 buy ($12594) · 12 sells ($1M) — 1 buying, 5 selling insiders
Activity heuristic: net selling (a transparent product heuristic from the counts above, not a prediction or advice)
Most recent open-market transaction: 2026-09-18. Based on Form 4 filings read through 2026-10-05; anything filed since is not yet included.
View full insider trading history → View SEC Form 3/4/5 filingsAsk about EXPO's insider activity →
Only open-market purchases (SEC code P) and sales (code S) are counted here. Option exercises, vesting/awards, gifts, and shares withheld for taxes are excluded — they are compensation or mechanical, not open-market conviction. Sales may be planned and non-discretionary (e.g. a Rule 10b5-1 plan) and are not necessarily bearish; open-market buying is not a recommendation to buy. Informational only — not financial advice.
U.S. House trading disclosures
U.S. House members publicly disclose their own, their spouse's, and dependent children's stock transactions under the STOCK Act. We hold 5 matched disclosures for EXPO from U.S. House Clerk Periodic Transaction Report filings.
U.S. House trading disclosures →Institutional ownership (13F)
5 institutional 13F filers reported holding EXPO as of 2026-06-30 (quarter-end position, filed within 45 days).
- Distinct 13F filers 5
- Reported shares held 8,231,814
- Reported value $483,701,371
reported quarterly holdings change (2026-03-31 → 2026-06-30): 1 new, 3 increased, 1 decreased, 1 exited. Change counts cover only managers that filed 13F reports in BOTH quarters, derived between two quarter-end snapshots — not same-day trades; a single manager is never said to have "bought" or "sold".
Institutional holdings are quarter-end long positions reported on SEC Form 13F-HR, filed up to 45 days after the quarter ends — they are delayed, are not real-time trades, exclude short positions and most non-US securities, and are not investment advice. Any increase/decrease is a reported change between two quarterly snapshots, not a same-day purchase or sale. These are quarter-end snapshots from the 13F filings on SEC EDGAR, filed within 45 days — not real-time, and any change is a difference between two quarterly reports, not a same-day trade. Informational only — not financial advice.
Ask about EXPO's institutional holders → See what each manager we track holds →
Short interest (FINRA)
EXPO had 3,080,474 shares of reported short interest as of the 2026-09-15 FINRA settlement date (delayed, bi-monthly; not real-time).
EXPO had 6.48% of its shares outstanding sold short as of the 2026-09-15 FINRA settlement date (percent of FLOAT would be higher — float is not disclosed in the source). FINRA reported 6.78 days to cover at the same settlement.
- Reported short interest (shares) 3,080,474
- Short interest (% of shares outstanding) 6.48%
- Prior settlement (shares) 2,956,304
- Reported change 4.2%
- Days to cover (reported) 6.78
Reported to FINRA as of the 2026-09-15 settlement date. Short interest is reported to FINRA and published on a delayed, bi-monthly schedule (as of a settlement date, disseminated roughly eight business days later) — it is NOT real-time, does not cover every venue or all US trading, and is not a short-squeeze prediction or investment advice. Days-to-cover is the value FINRA reports; percent of float is not shown because the source file carries no share-count denominator — where a percent appears it is of shares OUTSTANDING, the larger base, and is therefore a floor on percent of float. Informational only — not financial advice.
Competitors & peers
- Tetra Tech (TTEK)
- Jacobs Solutions (J)
- AECOM (ACM)
- Stantec (STN)
- FTI Consulting (FCN)
AI-enriched competitor set. Linked names are companies covered by stocks-llm; other named peers are shown for reference only.
Compare EXPO vs…
Frequently asked questions
What does EXPONENT INC (EXPO) do?
Exponent is a multi-disciplinary engineering and scientific consulting firm that provides solutions for complex technical, regulatory, and business problems. The company serves clients by investigating failures, assessing risks, and providing research and development support across diverse industries. Its professional staff comprises hundreds of scientists and engineers with expertise in various technical disciplines.
What sector is EXPONENT INC (EXPO) in?
EXPONENT INC (EXPO) is classified in the Industrials sector. Its industry is Technical and Engineering Consulting. It trades on NASDAQ.
Does EXPO pay a dividend?
Yes — EXPONENT INC (EXPO) pays a dividend, with an indicated yield of about 1.82% and at least 2 years of non-decreasing per-share dividends (SEC EDGAR XBRL) — we do not hold the year before it, so the real streak may be longer (market data, as of 2026-09-03). Informational only — not financial advice.
Who are EXPONENT INC's (EXPO) competitors?
Notable peers of EXPONENT INC (EXPO) include Tetra Tech, Jacobs Solutions, AECOM, Stantec and FTI Consulting. This peer set is informational only — not financial advice.
Has there been recent U.S. House stock trading in EXPO?
Yes — we hold 5 matched STOCK Act disclosures for EXPO from U.S. House Clerk Periodic Transaction Report filings. These are legally-required disclosures (often filed 30–45 days after the trade), may belong to a U.S. House member, their spouse, or a dependent child, and are not an indicator of company performance or investment advice.
Is EXPONENT INC (EXPO) overbought or oversold right now?
EXPONENT INC (EXPO) is currently neither overbought nor oversold — its 14-day RSI (a 0–100 momentum gauge) is 59, in the neutral middle (as of 2026-10-09). RSI describes recent price momentum, not a forecast — informational only, not financial advice.
Where does stocks-llm's data on EXPO come from?
Fundamentals come from SEC XBRL company filings for the figures marked with a fiscal year, and market data, as of 2026-09-03 for the rest; prices are market data, as of 2026-09-03; company filings and profile facts come from SEC EDGAR. All figures are delayed daily-close data shown with their as-of date — informational only, not financial advice.
Fundamentals: SEC XBRL company filings for the figures marked with a fiscal year, and market data, as of 2026-09-03 for the rest. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-10-09.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & market data, shown with their as-of date.